PAP 2024: Michael Galarraga Discusses "The State of Patient Access and Affordability”
March 20th 2024In an interview with Pharma Commerce Associate Editor Don Tracy, Michael Galarraga, LPC, ATR-BC, Pennsylvania State Representative, OutCare Health offers his thoughts on the breakout session and his experience in mental health counseling.
Cencora's Corey Ford Discusses the Future of the Inflation Reduction Act
February 29th 2024In an interview with Pharma Commerce Associate Editor Don Tracy, Corey Ford, VP, Reimbursement & Policy Insights, Cencora, offers his thoughts on where the Inflation Reduction Act will be five to 10 years from now.
Cencora VP of Reimbursement & Policy Insights Discusses Implications of the Inflation Reduction Act
February 28th 2024In an interview with Pharma Commerce Associate Editor Don Tracy, Corey Ford, VP, Reimbursement, Policy Insights, Cencora, provides a look at his recent webinar focused on the implications of the Inflation Reduction Act.
Adverse Event Reports Linked to Counterfeit Ozempic on the Rise
January 26th 2024Concerns regarding hypoglycemia potentially linked to a counterfeit version of Ozempic come at a time in which reports have grown regarding the improper use of GLP-1 receptor agonists for the purpose of cosmetic weight loss.